ITP - IMMUNE THROMBOCYTOPENIA
Clinical trials for ITP - IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new ITP - IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for ITP - IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost platelets in ITP patients
Disease control Not yet recruitingThis phase 2 trial tests whether adding baricitinib to standard TPO-RA therapy helps adults with immune thrombocytopenia (ITP) who did not respond to TPO-RA alone. One hundred participants will be randomly assigned to receive either baricitinib plus TPO-RA or TPO-RA alone for 14 …
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo aims to free ITP patients from lifelong medication
Disease control Not yet recruitingThis study tests whether adding all-trans retinoic acid (ATRA) to the drug avatrombopag can help adults with immune thrombocytopenia (ITP) maintain normal platelet levels without needing ongoing treatment. About 248 participants who have not responded well to first-line therapy o…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC